title: Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting: is there a paradox?
authors.forename: Federico
authors.initials: F
authors.lastname: Bizzarri
authors.forename: Giacomo
authors.initials: G
authors.lastname: Frati
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000601:surgery*; D000208:Acute Disease; D002315:Cardiopulmonary Bypass; D047549:Coronary Artery Bypass, Off-Pump; D006801:Humans; D008657:Metabolic Clearance Rate / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D019106:Postoperative Hemorrhage / Q000097:blood / Q000139:chemically induced; D011292:Premedication; D012307:Risk Factors; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced*; D000077466:Tirofiban; D014443:Tyrosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
chemical_list: D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D000077466:Tirofiban